SGH
CTLT

Sivik Global Healthcare’s CATALENT, INC. CTLT Stock Holding History

Sivik Global Healthcare’s Portfolio CTLT Stock Details CTLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,000
Closed -$2.82M – 52
2024
Q1 		$2.82M Buy
+50,000
New +$2.71M 0.66% 42
2023
Q4 		– Sell
-80,000
Closed -$3.64M – 44
2023
Q3 		$3.64M Buy
80,000
+10,000
+14% +$467K 1.84% 29
2023
Q2 		$3.04M Buy
+70,000
New +$3.07M 0.71% 34
2021
Q4 		– Sell
-60,900
Closed -$8.1M – 59
2021
Q3 		$8.1M Sell
60,900
-9,100
-13% -$1.14M 1.94% 19
2021
Q2 		$7.57M Sell
70,000
-2,500
-3% -$268K 1.48% 19
2021
Q1 		$7.63M Buy
72,500
+17,500
+32% +$1.95M 2.78% 15
2020
Q4 		$5.72M Sell
55,000
-37,500
-41% -$3.63M 2.33% 26
2020
Q3 		$7.92M Buy
+92,500
New +$7.82M 3.41% 8
2020
Q2 		– Sell
-100,000
Closed -$6.02M – 62
2020
Q1 		$6.02M Buy
+100,000
New +$5.46M 2.38% 21
2018
Q1 		– Sell
-75,000
Closed -$3.08M – 68
2017
Q4 		$3.08M Buy
75,000
+33,600
+81% +$1.37M 1.14% 41
2017
Q3 		$1.65M Buy
+41,400
New +$1.53M 0.56% 62

Other funds holding CTLT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Sivik Global Healthcare's CTLT Position: Q2 2024 in Review

Sivik Global Healthcare sold out of CATALENT, INC. (CTLT) in Q2 2024, closing a stake of 50,000 shares — an estimated $2.82M sold.

Sivik Global Healthcare first reported a position in CTLT in Q3 2017 and held it in 11 quarters. The position peaked at $8.1M in Q3 2021. 448 funds tracked by Wall St. Rank hold CTLT as of Q2 2024.

  • Sivik Global Healthcare reported no remaining CATALENT, INC. position as of Q2 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 50,000 CATALENT, INC. shares in Q2 2024, an estimated $2.82M.
  • Sivik Global Healthcare first reported a position in CATALENT, INC. in Q3 2017 and held it in 11 quarters.
  • Sivik Global Healthcare's CATALENT, INC. position peaked at $8.1M in Q3 2021.
  • 448 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2024.

Based on Sivik Global Healthcare's 13F filing for Q2 2024, filed 29 Jul 2024.